MSTN and Insulin resistance: Potential causality of the relationship between elevated myostatin and insulin resistance has been demonstrated in mice and murine culture models, where treatment with recombinant myostatin perturbed indices of insulin sensitivity and signalling, as well as glucose tolerance [17, 18], whereas inhibition of myostatin has been associated with improved insulin sensitivity [19–21].